Skip to content

Clinical trials

Completed Leukemia, Megakaryoblastic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Megakaryoblastic, Acute Status: Completed Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20012
20026
20032
200412
200511
200610
20076
200812
20095
20107
20119
20122
20136
20142

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)33
SWOG Cancer Research Network11
Case Comprehensive Cancer Center10
Fred Hutchinson Cancer Center6
Eastern Cooperative Oncology Group5
Children's Oncology Group4
ECOG-ACRIN Cancer Research Group4
Roswell Park Cancer Institute4
European Organisation for Research and Treatment of Cancer - EORTC3
Memorial Sloan Kettering Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Megakaryoblastic, Acute124
Leukemia, Myeloid, Acute121
Leukemia, Erythroblastic, Acute120
Leukemia, Monocytic, Acute114
Leukemia, Myelomonocytic, Acute113
Congenital Abnormalities88
Leukemia73
Leukemia, Basophilic, Acute39
Leukemia, Eosinophilic, Acute39
Precursor Cell Lymphoblastic Leukemia-Lymphoma30

Trials

Showing 51 to 75 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.